Active Ingredient History
Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis. Rilonacept is an interleukin 1 inhibitor. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia (Phase 2)
Arthritis, Juvenile (Phase 2)
Atherosclerosis (Phase 2)
Autoimmune Diseases (Early Phase 1)
Coronary Artery Disease (Phase 2)
Cryopyrin-Associated Periodic Syndromes (Phase 3)
Diabetes Mellitus, Type 1 (Phase 1)
Endothelial Cells (Phase 2)
Familial Mediterranean Fever (Phase 2)
Genetic Diseases, Inborn (Phase 3)
Gout (Phase 3)
Hepatitis, Alcoholic (Phase 2)
Inflammation (Phase 3)
Pericarditis (Phase 3)
Renal Insufficiency, Chronic (Phase 4)
Schnitzler Syndrome (Phase 2)
Scleroderma, Diffuse (Phase 1/Phase 2)
Scleroderma, Systemic (Phase 1/Phase 2)
Still's Disease, Adult-Onset (Phase 2)
Urticaria (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
